CL vs LYB
Colgate Palmolive Co. and LyondellBasell Industries N.v., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CL | LYB |
|---|---|---|
| Revenue | $20.4B | $30.2B |
| Net income | $2.1B | $-738.0M |
| Gross margin | 60.1% | 8.5% |
| Net margin | 11.1% | −2.4% |
| Return on equity | · | −6.5% |
| Diluted EPS | $2.63 | −$2.34 |
| Dividend / share | $2.08 | $5.45 |
| Payout ratio | · | −239.0% |
| Free cash flow | $3.6B | $384.0M |
| Equity | $54.0M | $10.1B |
| Net debt / equity | 124.04× | 0.88× |
| Current ratio | 0.83× | 1.77× |
| Revenue CAGR 5y | 4.4% | 1.7% |
| Profit CAGR 5y | −4.6% | · |
LYB bills 1.5× the revenue of CL, and LYB closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CL | LYB |
|---|---|---|
| FY2025 | $20.4B | $30.2B |
| FY2024 | $20.1B | $33.4B |
| FY2023 | $19.5B | $33.3B |
| FY2022 | $18.0B | $50.5B |
| FY2021 | $17.4B | $46.2B |
| FY2020 | $16.5B | $27.8B |
| FY2019 | $15.7B | $34.7B |
| FY2018 | $15.5B | $39.0B |
| FY2017 | $15.5B | $34.5B |
| FY2016 | $15.2B | $29.2B |
Bottom line
| Fiscal year | CL | LYB |
|---|---|---|
| FY2025 | $2.1B | $-738.0M |
| FY2024 | $2.9B | $1.4B |
| FY2023 | $2.3B | $2.1B |
| FY2022 | $1.8B | $3.9B |
| FY2021 | $2.2B | $5.6B |
| FY2020 | $2.7B | $1.4B |
| FY2019 | $2.4B | $3.4B |
| FY2018 | $2.4B | $4.7B |
| FY2017 | $2.0B | $4.9B |
| FY2016 | $2.4B | $3.8B |
15 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$9,771,000,000 | LYB |
| FY2024 | −$13,293,000,000 | LYB |
| FY2023 | −$13,879,000,000 | LYB |
| FY2022 | −$32,484,000,000 | LYB |
| FY2021 | −$28,752,000,000 | LYB |
| FY2020 | −$11,282,000,000 | LYB |
| FY2019 | −$19,034,000,000 | LYB |
| FY2018 | −$23,460,000,000 | LYB |
| FY2017 | −$19,030,000,000 | LYB |
| FY2016 | −$13,988,000,000 | LYB |
| FY2015 | −$16,701,000,000 | LYB |
| FY2014 | −$28,331,000,000 | LYB |
| FY2013 | −$26,642,000,000 | LYB |
| FY2012 | −$28,267,000,000 | LYB |
| FY2011 | −$31,449,000,000 | LYB |
LYB has reported the higher revenue in every one of these 15 fiscal years. The gap has narrowed since the earliest year compared.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
15 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +13.5 pp | CL |
| FY2024 | +11.1 pp | CL |
| FY2023 | +6.3 pp | CL |
| FY2022 | +3.2 pp | CL |
| FY2021 | +1.3 pp | CL |
| FY2020 | +12.2 pp | CL |
| FY2019 | +6.3 pp | CL |
| FY2018 | +4.4 pp | CL |
| FY2017 | −0.1 pp | LYB |
| FY2016 | +3.9 pp | CL |
| FY2015 | −4.0 pp | LYB |
| FY2014 | +4.4 pp | CL |
| FY2013 | +5.1 pp | CL |
| FY2012 | +9.2 pp | CL |
| FY2011 | +10.8 pp | CL |
The higher net margin has changed hands between CL and LYB over this period.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LYB's net margin has been more volatile than CL's over the 15 comparable fiscal years — 4.4 percentage points of standard deviation against 2.2.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CL and LYB over these 15 fiscal years — CL led in 13 and LYB in 2.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CL's return on equity has been more volatile than LYB's over the 9 comparable fiscal years — 221.5 percentage points of standard deviation against 13.3.
9 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
CL led in return on equity in every one of the 9 comparable fiscal years — a structural lead, not a recent swing.
9 of 18 comparable fiscal years — a year missing data on either side is not counted.